688331 RemeGen Co., Ltd.
- 28.59
- +1.71+6.36%
RemeGen Co., Ltd. News
Announcement of Remegen Pharmaceutical (Yantai) Co., Ltd. regarding the plan of the actual controller to increase shareholding in the company.
Rongchang Biotech's indicative announcement on the 2024 plan to issue A-shares to specific targets
Announcement of Rongchang Biotech on the issuance of A shares to specific targets in 2024, diluted immediate returns and compensation measures and commitments from related entities
Feasibility analysis report on the use of funds raised by Rongchang Biotech by issuing A-shares to specific targets in 2024
Demonstration analysis report on Rongchang Biotech's 2024 A-share issuance plan to specific targets
Rongchang Biotech's 2024 plan to issue A-shares to specific targets
Rongchang Biotech's announcement on the current issuance of A-shares to specific targets will not directly or through stakeholders provide financial support or compensation to investors participating in the subscription
Rongchang Biotech's shareholder dividend return plan for the next three years (2024-2026)
Announcement of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on the 2023 profit distribution plan
Rongchang Biopharmaceutical (Yantai) Co., Ltd. Limited Stock Listing and Circulation Notice
Announcement of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on the completion of the plan to increase the company\'s shares and the results of the increase in holdings of enterprises controlled by the actual controller
Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2022 A-share Restricted Stock Incentive Plan Class A Rights First Vesting Period First Vesting Results and Stock Listing Announcement
Announcement of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on the progress of enterprises controlled by the actual controller to increase the company\'s shares
Rongchang Biotech\'s announcement on the first vesting period of Class A rights in the company\'s 2022 A-share restricted stock incentive plan that met the conditions for ownership
Rongchang Biotech Supervisory Board\'s inspection opinion on the first vesting period list of Class A rights in the Company\'s 2022 A-share Restricted Stock Incentive Plan
Legal Opinion of Beijing Hairun Tianrui Law Firm on Rongchang Biopharmaceutical (Yantai) Co., Ltd.\'s 2022 A-share Restricted Stock Incentive Plan that met the conditions of ownership during the first vesting period and that the annulled portion was grante
Announcement of Rongchang Biotech on the abolition of part of the 2022 A-share Restricted Stock Incentive Plan to grant restricted stocks that have not yet been vested
Announcement of Rongchang Biotech on granting restricted shares for the first time to incentive recipients of the 2023 A-share Restricted Stock Incentive Plan
Legal Opinion of Shanghai Landi Law Firm on Rongchang Biopharmaceutical (Yantai) Co., Ltd.\'s 2023 Restricted Stock Incentive Plan Grants Restricted Shares for the First Time
List of incentive recipients granted for the first time in Rongchang Biotech\'s 2023 A-share Restricted Stock Incentive Plan (as of the initial grant date)
Analysis
Price Target
No Data
